This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
In a five-times oversubscribed offering, generic drug company Zentiva BV has raised €84.85mm ($102.7mm) with a 5.6mm-share IPO, pricing its common shares at €15.24 ($18.36) apiece. The firm will trade on the Prague Stock Exchange; its global depositary shares (each of which equals one common share) will be listed on the London Stock Exchange. Zentiva's majority shareholder Warburg Pincus is selling $100mm in a secondary offering, leaving Pincus with a slightly over 50% stake in the company.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?